“Shocking, Alzheimer’s disease has been conquered by pharmaceutical companies from the East.”
"After 20 years of waiting! The new Alzheimer's drug developed by Chinese scientists has entered clinical trials and will be launched soon!"
"Su Daqiang is saved, China's original new drug for the treatment of Alzheimer's disease is available!"
“When the dragon from the east roars, even Alzheimer’s disease will tremble and surrender!”
“After years of research, Huaxia’s plan has filled the gap in anti-Alzheimer’s drugs in the past 18 years!”
"Alzheimer's disease can be cured, and China's original new drug has attracted international attention!"
"Overnight, from Alzheimer's disease to memorizing the last fifty digits of pi, focus on the miracle of new drugs for Alzheimer's disease!"
“Into science, the story behind Sanqing Pharmaceutical’s continuous efforts to conquer terminal diseases!”
“China’s new Alzheimer’s drug triggers controversy: Don’t be too happy too early!”
Global media enthusiastically reported the relevant news, and the news spread at the speed of light.
Especially the domestic media, every report is the same as that produced by the UC Shock Department, all exaggerated.
Alzheimer's disease is an incurable disease that global pharmaceutical companies are unable to cure, and it is even more despairing than cancer.
Although the domestic pharmaceutical company Green Sunshine has also developed a similar new drug, the clinical report has not been published in Nature magazine.
Moreover, the drug has been controversial since the beginning of the interview. Chang Sanwei, the well-known biological scientist and director of the Department of Biology at Peking University, even criticized the clinical data for falsification.
Not to mention, the pharmaceutical company has been in the middle of negative headlines for false anti-cancer advertising.
Compared with Sanqing, a pharmaceutical company that has invented a miracle anti-cancer drug and actively lowered its price to include it in medical insurance, it is natural that it cannot keep up even if it is trying to catch up.
As a result, the media rushed to grab the hot spots and hyped Sanqing's new medicine 360 degrees without any blind spots.
Not only doctors and pharmaceutical companies around the world, but also many ordinary people learned about this from the news.
In an instant, the entire Internet was buzzing with excitement, and half of the top 10 most searched topics were about the three new medicines.
"It's Sanqing again, awesome plus!"
"Cancer, Alzheimer's disease, what else can Sanqing not defeat?"
"I beg Sanqing to develop the elixir of life!"
"I don't have high requirements, just a genetic mutation drug. I just want to become as smart and handsome as Mr. Wei."
"Great, my grandfather is saved. I will apply for clinical trial drugs right away."
"Don't worry upstairs, I have read the original article in Nature magazine. This drug is only for early-stage patients with Alzheimer's disease. If it is late-stage patients, it may not have much effect."
"Kneel down to the god upstairs, I can actually understand the original article."
"This has broken the world record. It's great. Sanqing is the pride of China. It has always won glory for the country and never stopped."
"I would like to ask, is there no such medicine available abroad now?"
"It seems that before Sanqing, the only products that could treat Alzheimer's disease were domestic Green Sunshine's trehalose capsules and a new drug from Yingguo Bogen."
"Don't talk nonsense if you don't understand. Seaweed extract can treat Alzheimer's disease. Do you believe it? There is also Bogen's new drug. It is said that it was canceled because it had no effect at first. Later, the effect was suddenly discovered and it was applied for marketing. However, after passing the FDA Later, ten FDA medical experts resigned angrily, and you know the truth."
"Hiss, Internet powerhouses are so terrifying and know so much. These two medicines seem to be a bit deep, so who dares to take them?"
"That's right, but now there are new drugs from Sanqing. Sanqing will definitely not cheat, so early patients can really be saved."
Eagle Country, Pfizer headquarters.
All the top executives from the board of directors gathered, including the heads of several drug development laboratories.
The CEO of Pfizer looked at everyone, and the secretary sent copies of the information to everyone.
He slowly said: "This is a clinical treatment paper excerpted from the journal Nature. I believe most of you have read it. If you haven't, hurry up and read it."
Everyone opened the file and looked more and more surprised, with expressions of disbelief on their faces.
Some people can't help but ask: "Is this paper true or false? Is the data authentic and credible?"
Others also nodded in agreement: "Yes, Chinese scholars have always had a tradition of falsifying data and cannot be trusted easily."
Pfizer CEO did not speak, but looked at Andre sitting in the front row and nodded.
Andre spoke calmly and steadily, obviously well prepared: "The data is real, and I have verified it through Pfizer's branch in China. Moreover, Sanqing is the one who develops new drugs and is our partner. I believe everyone should Remember the Sanqing anti-cancer drug, this anti-cancer drug brought us very huge profits, allowing Pfizer to quickly occupy the high-end market of anti-tumor drugs in Europe and Eagle."
Everyone was shocked when they heard it, it was Sanqing again?
This time they looked at the paper seriously, with serious expressions on their faces. After reading it, they looked at each other, and no one spoke for a while.
Pfizer CEO breaks silence: "What do you think?"
"I still doubt it!" This is the head of a drug research and development laboratory. He said confidently: "Alzheimer's disease is absolutely impossible to be cured. My laboratory has not been successful after many years of research. All other The drugs developed by pharmaceutical giants can only delay the disease, and the drug Sanqing is only for early-stage patients."
"Many symptoms of early-stage patients are not obvious and often recur. Maybe the patient's condition is not serious to begin with. And the patient has only taken this medicine for a month, and can he be cured in one month? Do you believe it? Maybe the disease is only temporarily controlled. "
Others also began to question: "It says that the drug is still in the second phase of clinical trials. It only provides treatment data on a dozen patients within one month. There is no complete clinical data, and even the side effects are not fully noted."
"This is not a successful drug at all, and Nature is too irresponsible. How could it publish such a paper that lacks sufficient data support?"
Andre defended: "Maybe it's because the conditions of these more than a dozen patients were under control and completely cured within a month. Therefore, it became the first paper in the world to come up with specific cases of successful treatment," magazine editor-in-chief Just let it pass.”
"But after all, this is only a one-month effect. It is difficult to say what will happen later. Patients may develop drug resistance and then relapse. It is too arbitrary to conclude like this."
"Even if you can keep taking this drug to control your condition, are there any side effects? You must know that many drugs have fatal flaws only after they have been taken for a long time."
There was a lot of discussion, but they could not completely agree with the conclusion of this paper.
Pfizer CEO suddenly said: "There is one more thing I want to tell everyone."
He looked around and said in a deep voice: "The head of the laboratory that developed this new drug is called Chen Yiqing. He used to work in Pfizer's neurodegenerative disease drug research and development team and is a core R&D member. Moreover, the treatment principle of this drug is the same as that of the original drug." Pfizer's research and development direction is the same, both are γ-secretase inhibitors. Do you think it is possible that it has stolen our core technology?"
Everyone was stunned, and the expressions on their faces became extremely exciting.
"This possibility is not impossible, but Chen has been out of office for several years. It is really hard to convince people to make accusations in this regard." Someone said cautiously: "And we had already announced that we would give up research in this area. All experts have also been dismissed."
"Yes, when Sanqing develops new drugs, it must register a patent. If it misappropriates our patent, it will not pass the patent approval."
"But you have forgotten that this drug has just been developed, and it was developed in the East. It has not registered a patent in Eagle Country. It is difficult to tell whether similar technology is used."
Andre suddenly said: "Everyone, if there is no real evidence, you cannot accuse Sanqing so casually. After all, it is Pfizer's long-term strategic partner. If such words get out and anger Sanqing, it will not do us any good. On the contrary, the loss was huge.”
"The most important thing is that we have given up the research and development of new drugs for Alzheimer's disease. There is no conflict of interest with Sanqing in this regard. We can even seek authorization cooperation for this new drug in the future. There is absolutely no need to do such a thing."
Someone nodded and said: "Yes, after all, it is normal for scientific researchers to leave. As long as there is no infringement of patents, the use of technology should be free. You cannot make malicious speculations before seeing detailed data."
Having said that, judging from the expressions on many people's faces, they still have doubts in their hearts.
The CEO of Pfizer fell into deep thought and said after a while: "Let's see, some unknown person will inadvertently leak this news to the media. They are pervasive. When encountering such a thing, they will naturally dig into the truth behind it. That has nothing to do with us. But You must all keep this matter a secret."
Everyone smiled and nodded, with expressions on their faces as if they were watching a good show.
